NEXGEL INC

NXGLNASDAQ

🏆 #3867 by market capUS Equity

$451.54▲ $31.29 (+6.93%)

Simulated price

1h—

24h▲ 6.9%

7d—

14d—

30d—

1y—

🏦Market Cap

$5M

Small Cap

📈Revenue Growth (YoY)

+10.1%

Healthy

📊Gross Margin

38.9%

Healthy

💵FCF Margin

—

⚖️P/S Ratio

0.4x

Cheap

Otter Score

Fair

No chart data available for NXGL.

Trading Snapshot

Day Range: $449.19 – $458.85
52-Week Range: $0.33 – $2.89
Volume: $5.91B
Avg Volume: $4.25B
Shares Outstanding: 9.2M
Next Earnings: Sep 14, 2026

Fundamentals Snapshot

Annual Revenue: $11M
Last Q Revenue: $3M
P/E Ratio: —
P/S Ratio: 0.4x
EPS (TTM): $-0.40
Dividend Yield: —

Why Investors Own NXGL

✓High-growth profile — revenue up +15.7% YoY with expanding US Equity exposure.
✓Healthy economics — 35% gross margin and 24% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$11M▲ +11.0% YoY

Gross Margin (TTM)

34.6%▲ +4.3% YoY

Operating Income (TTM)

$3M▲ +11.0% YoY

Free Cash Flow (TTM)

$3M▲ +11.0% YoY

About NEXGEL INC

NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.

🦦